CD164 and breast carcinoma: In this study, we investigated the functional relevance of siRNA-mediated knockdown of CD164 in breast cancer cells by means of CCK-8, EdU incorporation, and colony development assays, so evaluating cell viability, proliferation, and clonogenicities.